Mike Sathekge is the Professor and head of Nuclear Medicine at University of Pretoria & Steve Biko Academic Hospital as well as the President & CEO of Nuclear Medicine Research Infrastructure (NuMeRI) in South Africa. He has conducted several early phase clinical studies in prostate cancer as a principal investigator and is in the forefront regarding treatment of targeted alpha therapy. Prof Sathekge has published over 300 peer-reviewed articles, excluding abstracts and book chapters. Mike is an Editor-in-Chief of Seminars in Nuclear Medicine. He is also an Associate Editor of the European Journal of Nuclear Medicine and Molecular Imaging and Journal of Nuclear Medicine. Mike is a member of The Lancet Oncology’s international advisory board. Prof Sathekge is the head of the IAEA Anchor Center for Rays of Hope for Cancer care in South Africa and Chair of the Africa Health Research Institute. He is a recipient of numerous international and national merit awards.
